Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    savita thakur thakur
    savita thakur thakur
      • Home
      • savita thakur thakur

      Articles By : savita thakur thakur

      Bristol-Myers Squibb to pay 19.5 mln dollers to settle off-label promotion case

      Bristol-Myers Squibb to pay 19.5 mln dollers to settle off-label promotion case

      savita thakur thakur12 Dec 2016 11:24 AM IST
      WASHINGTON: Drugmaker Bristol-Myers Squibb Co will pay $19.5 million to resolve multi-state allegations that it improperly promoted a schizophrenia...
      Synergy Pharmaceuticals bowel drug succeeds in key study

      Synergy Pharmaceuticals bowel drug succeeds in key study

      savita thakur thakur12 Dec 2016 9:42 AM IST
      Synergy Pharmaceuticals Inc said its experimental oral drug, plecanatide, met the main goal of a late-stage study on irritable bowel syndrome patients...
      Pharma, biotech stocks fall after Trump comment on drug prices

      Pharma, biotech stocks fall after Trump comment on drug prices

      savita thakur thakur11 Dec 2016 1:12 PM IST
      NEW YORK- Shares of U.S. pharmaceutical and biotechnology companies tumbled after President-elect Donald Trump said he would "bring down drug...
      Incentives and discounts to make health insurance universal: Irdai

      Incentives and discounts to make health insurance universal: Irdai

      savita thakur thakur11 Dec 2016 9:29 AM IST
      NEW DELHI: Irdai Chairman T S Vijayan said there is a need to incentivise people who are not inclined to buy health insurance in form of free...
      New version of Health Assurance launched by Max Bupa

      New version of Health Assurance launched by Max Bupa

      savita thakur thakur10 Dec 2016 1:14 PM IST
      New Delhi: Max Bupa has unveiled the new edition of Health Assurance, a unique combination of three covers, making it the one of the most...
      Indian pharma industry facing growth headwinds: ICRA

      Indian pharma industry facing growth headwinds: ICRA

      savita thakur thakur10 Dec 2016 10:27 AM IST
      NEW DELHI: Indian pharmaceutical industry will grow at a slower pace due to sluggish growth in the US market, increased competition leading to price...
      EU regulator accepts Sanofi/Regeneron Dupixent product for review

      EU regulator accepts Sanofi/Regeneron Dupixent product for review

      savita thakur thakur10 Dec 2016 9:27 AM IST
      The European Medicines Agency (EMA), the European Union's health regulator, has accepted for review the Dupixent product being developed by drug...
      USFDA made 9 observations post Halol unit inspection: Sun Pharma

      USFDA made 9 observations post Halol unit inspection: Sun Pharma

      savita thakur thakur9 Dec 2016 11:41 AM IST
      NEW DELHI: Drug major Sun Pharmaceutical Industries said that the US health regulator made nine observations after the completion of inspection of its...
      Cipla gets final USFDA nod for Baraclude tablets

      Cipla gets final USFDA nod for Baraclude tablets

      savita thakur thakur9 Dec 2016 11:39 AM IST
      Mumbai: Cipla Ltd, a global pharmaceutical company which uses cutting edge technology and innovation to meet the everyday needs of all patients, has...
      Samara Capital to invest 25 million dollars in Sahajanand Medical Technologies

      Samara Capital to invest 25 million dollars in Sahajanand Medical Technologies

      savita thakur thakur9 Dec 2016 11:38 AM IST
      Mumbai: Mid-market private equity firm Samara Capital Partners Fund II (“Samara”) has signed definitive agreements to invest up to USD 25MM in...
      Indian share in global herbal medicinal market is 0.5 Percent: Govt

      Indian share in global herbal medicinal market is 0.5 Percent: Govt

      savita thakur thakur21 Nov 2016 11:50 AM IST
      New Delhi: India's share in the global herbal medicinal market is a minuscule 0.5 per cent at USD 358.60 million, government informed the Lok...
      Law will be made for certification for medical devices: Kerala Minister

      Law will be made for certification for medical devices: Kerala Minister

      savita thakur thakur21 Nov 2016 11:49 AM IST
      Thiruvananthapuram: The Centre would work on a legislation for the certification of medical devices and equipment, Union Minister of State for Science...
      PrevNext

      Popular Stories

      • Email: info@medicaldialogues.in
      • Phone: 011 - 4372 0751

      Website Last Updated On : 13 Oct 2022 5:14 AM GMT
      Company
      • About Us
      • Contact Us
      • Our Team
      • Reach our Editor
      • Feedback
      • Submit Article
      Ads & Legal
      • Advertise
      • Advertise Policy
      • Terms and Conditions
      • Privacy Policy
      • Editorial Policy
      • Comments Policy
      • Disclamier
      Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

      Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

      © 2025 - Medical Dialogues. All Rights Reserved.
      Powered By: Hocalwire
      X
      We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok